# Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis

> **NCT02901288** · PHASE4 · UNKNOWN · sponsor: **Beijing Chest Hospital** · enrollment: 3900 (estimated)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

- **DRUG:** Isoniazid
- **DRUG:** Rifampicin
- **DRUG:** Pyrazinamide
- **DRUG:** Ethambutol
- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT02901288
- **Lead sponsor:** Beijing Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 3900 (ESTIMATED)
- **Last updated:** 2017-03-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02901288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02901288, "Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02901288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*